Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Aaberg

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Oxford Medical Case Reports|July 16, 2025
Ocular complications of tussock moth cocoon associated injuryHenry Zou, Thomas Aaberg, Brooke Geddie
Journal of Pediatric Ophthalmology and Strabismus|December 5, 2012
Conjunctival angiolymphoid hyperplasia with eosinophilia in a childLiliya Shevchenko, Thomas Aaberg, Hans E Grossniklaus
Journal of Vitreoretinal Diseases|April 3, 2023
Unilateral Multiple Extramedullary Plasmacytoma of the Choroid and Conjunctiva: A Case ReportShymaa Mohamed, Truman Silvasi, Anthony Kubat, et al.
Retina (Philadelphia, Pa.)|August 22, 2009
Diagnostic and therapeutic challengesGiuseppe Querques, Nicola Delle Noci, Thomas Aaberg, et al.
Ocular Oncology and Pathology|August 12, 2022
Intraocular Lens and Lens Capsule Spread of Iridociliary Melanoma: Clinical and Histopathologic Features of 2 CasesCorrina P Azarcon, Jill R Wells, Thomas Aaberg, et al.
Investigative Ophthalmology & Visual Science|August 4, 2025
Long-Term Durability of Ciliary Neurotrophic Factor-Releasing Revakinagene Taroretcel-lwey in Individuals With Retinal Degenerative DisordersKonrad Kauper, Arne Nystuen, Lisa Orecchio, et al.
Investigative Ophthalmology & Visual Science|June 23, 2023
Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year OutcomesStephanie Trejo Corona, Cecilia Villanueva Boone, Amna M Ali, et al.
NEJM Evidence|July 22, 2025
Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2Emily Y Chew, Mark Gillies, Glenn J Jaffe, et al.
Brachytherapy|March 7, 2017
Visual acuity, oncologic, and toxicity outcomes with <sup>103</sup>Pd vs. <sup>125</sup>I plaque treatment for choroidal melanomaKirtesh R Patel, Roshan S Prabhu, Jeffrey M Switchenko, et al.
Investigative Ophthalmology & Visual Science|April 27, 2013
Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt diseaseKatie Binley, Peter Widdowson, Julie Loader, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Oxford Medical Case Reports|July 16, 2025
Ocular complications of tussock moth cocoon associated injuryHenry Zou, Thomas Aaberg, Brooke Geddie
Journal of Pediatric Ophthalmology and Strabismus|December 5, 2012
Conjunctival angiolymphoid hyperplasia with eosinophilia in a childLiliya Shevchenko, Thomas Aaberg, Hans E Grossniklaus
Journal of Vitreoretinal Diseases|April 3, 2023
Unilateral Multiple Extramedullary Plasmacytoma of the Choroid and Conjunctiva: A Case ReportShymaa Mohamed, Truman Silvasi, Anthony Kubat, et al.
Retina (Philadelphia, Pa.)|August 22, 2009
Diagnostic and therapeutic challengesGiuseppe Querques, Nicola Delle Noci, Thomas Aaberg, et al.
Ocular Oncology and Pathology|August 12, 2022
Intraocular Lens and Lens Capsule Spread of Iridociliary Melanoma: Clinical and Histopathologic Features of 2 CasesCorrina P Azarcon, Jill R Wells, Thomas Aaberg, et al.
Investigative Ophthalmology & Visual Science|August 4, 2025
Long-Term Durability of Ciliary Neurotrophic Factor-Releasing Revakinagene Taroretcel-lwey in Individuals With Retinal Degenerative DisordersKonrad Kauper, Arne Nystuen, Lisa Orecchio, et al.
Investigative Ophthalmology & Visual Science|June 23, 2023
Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year OutcomesStephanie Trejo Corona, Cecilia Villanueva Boone, Amna M Ali, et al.
NEJM Evidence|July 22, 2025
Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2Emily Y Chew, Mark Gillies, Glenn J Jaffe, et al.
Brachytherapy|March 7, 2017
Visual acuity, oncologic, and toxicity outcomes with <sup>103</sup>Pd vs. <sup>125</sup>I plaque treatment for choroidal melanomaKirtesh R Patel, Roshan S Prabhu, Jeffrey M Switchenko, et al.
Investigative Ophthalmology & Visual Science|April 27, 2013
Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt diseaseKatie Binley, Peter Widdowson, Julie Loader, et al.
Pageof 2